Nature Medicine, Published online: 03 July 2026; doi:10.1038/s41591-026-04493-5
The authors present a framework for the selection of immune aging biomarkers suitable for clinical trials in geroscience, alongside a translational roadmap for biomarker development to support the next generation of clinical studies on immune aging.